Ion Beam Applications, S.A. announced group revenue results for the first quarter ended March 31, 2016. For the period, the group reported revenues of EUR 64.6 million, up 10.2% year-on-year, driven by excellent revenue recognition of Proton Therapy (PT) projects, offsetting slow revenue recognition in Other Accelerators and Dosimetry.

The company reiterated earnings guidance for the full year 2016. For the full year, the company expected revenue growth greater than 20%, with double digit annual growth thereafter and 2016 operating margin of 11%, increasing to 13%-15% by 2018. Net debt, if any, is expected to stay limited in the years to come.